Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

6 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(41.7%)
Phase 4
5(41.7%)
Phase 3
1(8.3%)
Phase 1
1(8.3%)
12Total
N/A(5)
Phase 4(5)
Phase 3(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT07500610Recruiting

Observing the Role of Inflammation in Peripheral Artery Disease and Its Impact on Heart and Mobility Health: PANACEA-O.

Role: lead

NCT07369856Not ApplicableRecruiting

Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure

Role: lead

NCT06378775Not ApplicableNot Yet Recruiting

Robotically-assisted Minimally-invasive Direct Coronary Artery Bypass With Stenting, Randomized Against Coronary Artery Bypass Graft Surgery

Role: lead

NCT02008786Phase 4Terminated

Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD

Role: lead

NCT05859048Not ApplicableRecruiting

Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure

Role: lead

NCT06103123Unknown

MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study

Role: lead

NCT04906356Recruiting

Canadian SCAD Study

Role: lead

NCT01479140Completed

Prevalence and Long-term Impact of Non-atherosclerotic CAD

Role: lead

NCT02000661Phase 4Terminated

Routine Versus Selective Use of FFR to Guide PCI

Role: lead

NCT03642886Not ApplicableUnknown

Detraining on Atrial Fibrillation

Role: lead

NCT02666651Phase 4Unknown

Regional Tolvaptan Registry

Role: lead

NCT02533752Unknown

Canadian WATCHMAN Registry

Role: lead

NCT02188069Unknown

Canadian SCAD Study

Role: lead

NCT01373411Phase 4Completed

Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery

Role: lead

NCT01065103Not ApplicableCompleted

Fractional Flow Reserve (FFR) Stability in Non-Culprit Vessels at ST Elevation Myocardial Infarction(STEMI)

Role: lead

NCT00846378Phase 1Suspended

Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction

Role: collaborator

NCT00111566Phase 4Completed

BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention

Role: lead

NCT01368991Phase 3Unknown

Clinical Trial of Kryptonite for Prevention of Sternal Complications in High Risk Patients Undergoing Cardiac Surgery

Role: lead

All 18 trials loaded